DT

Dominique Takizawa

Director Director DIN 02704660
DIN 02704660 First appointment Jul 2009 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Dominique Takizawa

Data last updated:

Dominique Takizawa was a Director at Avesthagen Limited (2010–2011) and Director at Sanofi Healthcare India Private Limited (2009). The companies operate in Life Sciences.

DIN 02704660
Primary Designation Director
Industry Life Sciences
First Appointment 17 Jul 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avesthagen Limited U73100KA1998PLC030671
Director17 Feb 20101998₹1.57 Cr (FY 2024)Under Cirp
Director17 Jul 20091993₹1,726 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avesthagen Limited
Sanofi Healthcare India Private Limited
Premium access

Shareholding and investment profile for Dominique Takizawa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dominique Takizawa

Dominique Takizawa was first appointed on 17 Jul 2009 as Director at Sanofi Healthcare India Private Limited. The most recent appointment on record is 17 Feb 2010 at Avesthagen Limited.

Dominique Takizawa held 2 earlier board appointments: Avesthagen Limited (Director, 17 Feb 2010 to 31 May 2011); Sanofi Healthcare India Private Limited (Director, 17 Jul 2009 to 31 Aug 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available